Center for Disease Control and Prevention, Healthy Brain Initiative, The 2018-2023 Road Map
Early detection and management when it matters. 3 main pillars: (1) sensitivity beyond MCI (2) Test. re-test reliability (3) Lack of bias.
Testimonials
Incorporating Cognivue Thrive can expand the diagnostic assessment of the patient’s overall health picture, allowing more comprehensive vision care.
Dr. Michael Pier, OD.Recent Articles
-
Validity, Reliability, and Psychometric Properties of a Computerized, Cognitive Assessment Test (Cognivue)
-
Comparison of the Cognivue Quantitative Assessment Tool and SLUMS to Classify the Risk of Cognitive Impairment
-
Validation, Reliability, and Psychometric Properties of Cognivue, A Quantitative Assessment of Cognitive Impairment
News
Cognivue, Inc. Initiates Nationwide Clinical Study to Assess Post-COVID-19 Syndrome (Long Haul Syndrome)
ROCHESTER, N.Y., July 8, 2021—Neuroscience company Cognivue, Inc. today announced the initiation of COG-COVID19, an open-label, prospective, two-armed comparison clinical study to assess the impact of COVID-19 on cognitive function. Researchers from…
Sign-up to schedule a Cognivue demo!
Click Here